• Publications
  • Influence
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.
Walter T. Hughes, Donald Armstrong, Gerald P. Bodey, Eric J. Bow, Arthur E. Brown, Thierry Calandra, Ronald Feld, Philip A. Pizzo, Kenneth V. I. Rolston, Jerry L. Shenep, and Lowell S. Young St. JudeExpand
  • 1,742
  • 78
  • PDF
Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever—Reply
To THE EDITOR-In their recent review, Hughes et al. [1] discuss the use of empiric antibiotic therapy for unexplained fever in neutropenic patients. We are concerned about their recommendationsExpand
  • 406
  • 17
  • PDF
1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America.
This is the first in a series of practice guidelines commissioned by the Infectious Diseases Society of America through its Practice Guidelines Committee. The purpose of these guidelines is toExpand
  • 601
  • 11
Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS
Mycobacterium avium complex infection is common in patients with AIDS. Experimentally infected mice have been treated successfully with azithromycin, a macrolide antibiotic. We report an uncontrolledExpand
  • 179
  • 7
Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration.
The use of empirical antimicrobial therapy has significantly reduced the morbidity and mortality associated with untreated infections in febrile neutropenic patients. This guideline describesExpand
  • 86
  • 6
Antimicrobial synergism in the therapy of gram-negative rod bacteremia.
To determine if antimicrobial synergism might affect the results of treatment of gram-negative rod infections, 444 bacteremias from 1972 through 1974 were studied. On these, 173 were treated with twoExpand
  • 160
  • 4
Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.
Serum antibodies to exotoxin A and type-specific lipopolysaccharide were measured by passive hemagglutination in 52 patients with Pseudomonas aeruginosa septicemia. Their comparative protectiveExpand
  • 160
  • 4
  • PDF
Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations.
During the last 2 decades, Gram-negative rod bacteremia has become the leading infectious disease problem in American hospitals. With improvements in conventional microbiologic techniques, bacteremicExpand
  • 166
  • 4
Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins.
Invasive, disease-associated members of the Mycobacterium avium complex are facultative intracellular pathogens of mammalian macrophages. The mechanism(s) by which M. avium is ingested by mononuclearExpand
  • 124
  • 4
Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex.
The effect of amikacin and two new macrolides (roxithromycin and azithromycin) used either alone or in combination with recombinant tumor necrosis factor (TNF) to inhibit or kill Mycobacterium aviumExpand
  • 62
  • 4